BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2022 10:23:38 AM | Browse: 434 | Download: 797
 |
Received |
|
2021-11-14 19:36 |
|
Peer-Review Started |
|
2021-11-14 19:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-07 02:42 |
|
Revised |
|
2022-04-23 19:17 |
|
Second Decision |
|
2022-06-15 02:59 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-18 21:06 |
|
Articles in Press |
|
2022-06-18 21:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-06-28 07:06 |
|
Publish the Manuscript Online |
|
2022-07-07 10:23 |
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Minireviews |
| Article Title |
Medicinal nicotine in COVID-19 acute respiratory distress syndrome, the new corticosteroid
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Farrukh Ahmad |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Farrukh Ahmad, MD, Staff Physician, Department of Internal Medicine, Saint Vincent Hospital, 123, Summer Street, Worcester, MA 01608, United States. farrukh2.ahmad@stvincenthospital.com |
| Key Words |
COVID-19; Acute respiratory distress syndrome; Medicinal nicotine; Cholinergic anti-inflammatory pathway; Corticosteroid |
| Core Tip |
Cholinergic anti-inflammatory pathway is novel pathway of the inflammatory reflex. Activation of this pathway can suppress maladaptive inflammatory response seen in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS). Nicotine is a potent activator of this pathway and may offer benefits in the management of COVID-19 ARDS, via immune suppressive effects similar to dexamethasone. |
| Publish Date |
2022-07-07 10:23 |
| Citation |
Ahmad F. Medicinal nicotine in COVID-19 acute respiratory distress syndrome, the new corticosteroid. World J Crit Care Med 2022; 11(4): 228-235 |
| URL |
https://www.wjgnet.com/2220-3141/full/v11/i4/228.htm |
| DOI |
https://dx.doi.org/10.5492/wjccm.v11.i4.228 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
